K2M expects 2017 revenue of $257M — 6 notes

Megan Wood -   Print  |

K2M reported its 2017 preliminary fourth-quarter and full-year results.

Here are the company's fourth quarter results:


1. K2M will likely see revenue between $67.3 million and $67.9 million, reflecting a 9 percent to 10 percent year-over-year increase.


2. Domestically, the revenue will land somewhere between $51.7 million and $52 million, a 9 percent year-over-year boost.


3. Specifically, the company's U.S. complex spine line grew 8 percent year-over-year and the minimally invasive surgery line grew 15 percent year-over year. The U.S. degenerative segment saw an 8 percent boost year-over-year.


4. K2M's international revenue hit between $15.6 million and $15.9 million, an 11 percent to 13 percent increase year-over-year.


Here are K2M's FY 2017 results:


5. The company reported revenue between $257.5 million $258.1 million, a 9 percent year-over-year increase.


6. K2M anticipates its full-year 2017 net loss and adjusted EBITDA to reflect its reported guidance.


More articles on devices:
Medtronic, DePuy Synthes & more: 8 device company mergers, acquisitions & agreements
DJO Global reports patient information breach at Las Vegas hospital: 5 things to know
NuVasive's US procedure volumes stay slow in 2017, international revenue up: 5 things to know


© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers